[HTML][HTML] Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: pharmacodynamic results from the UNVEIL study
B Strober, A Alikhan, B Lockshin, R Shi, J Cirulli… - Journal of …, 2019 - Elsevier
Background Pharmacodynamic (PD) subanalyses of clinical trials in patients with moderate
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
[HTML][HTML] Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study
B Strober, A Alikhan, B Lockshin, R Shi… - Journal of …, 2019 - jdsjournal.com
Background Pharmacodynamic (PD) subanalyses of clinical trials in patients with moderate
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study
B Strober, A Alikhan, B Lockshin… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Pharmacodynamic (PD) subanalyses of clinical trials in patients with moderate
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study.
B Strober, A Alikhan, B Lockshin, R Shi… - Journal of …, 2019 - europepmc.org
Background Pharmacodynamic (PD) subanalyses of clinical trials in patients with moderate
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …
to severe psoriasis demonstrated the efficacy of apremilast correlated with reductions in …